Patient representatives' views on patient information in clinical cancer trials.

about

Patients' reasoning regarding the decision to participate in clinical cancer trials: an interview study

P2860

Q58795832-5CBA2E14-0407-4B1F-92C2-7C1B204ACE3F

P2860

Patient representatives' views on patient information in clinical cancer trials.

Item

http://www.wikidata.org/entity/Q35910478

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Patient representatives' views on patient information in clinical cancer trials.

@ast

Patient representatives' views on patient information in clinical cancer trials.

@en

type

Item

label

Patient representatives' views on patient information in clinical cancer trials.

@ast

Patient representatives' views on patient information in clinical cancer trials.

@en

prefLabel

Patient representatives' views on patient information in clinical cancer trials.

@ast

Patient representatives' views on patient information in clinical cancer trials.

@en

P1476

Patient representatives' views on patient information in clinical cancer trials.

@en

P2093

Christina Carlsson

http://www.w3.org/2001/XMLSchema#string

Pia Dellson

http://www.w3.org/2001/XMLSchema#string

P2860

Quality of informed consent in cancer clinical trials: a cross-sectional survey.

Interventions to improve research participants' understanding in informed consent for research: a systematic review.

A systematic review highlights threats to validity in studies of barriers to cancer trial participation.

Improvement of informed consent and the quality of consent documents.

Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS).

Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death.

Importance of format and design in print patient information.

Towards optimised information about clinical trials; identification and validation of key issues in collaboration with cancer patient advocates.

Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families?

Levels of knowledge and perceived understanding among participants in cancer clinical trials - factors related to the informed consent procedure.

P2888

s12913-016-1272-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12913-016-1272-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mef Nilbert

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292675379

http://www.w3.org/2001/XMLSchema#string

P6179

1036036829

http://www.w3.org/2001/XMLSchema#string

P698

26831330

http://www.w3.org/2001/XMLSchema#string

P932

4736467

http://www.w3.org/2001/XMLSchema#string

Patient representatives' views on patient information in clinical cancer trials.

about

P2860

P2860

Patient representatives' views on patient information in clinical cancer trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932